-
1
-
-
3343012046
-
Remarkable increase in central Japan in 2001-2002 of Neisseria gonorrhoeae isolates with decreased susceptibility to penicillin, tetracycline, oral cephalosporins, and fluoroquinolones
-
Ito M, Yasuda M, Yokoi S et al. Remarkable increase in central Japan in 2001-2002 of Neisseria gonorrhoeae isolates with decreased susceptibility to penicillin, tetracycline, oral cephalosporins, and fluoroquinolones. Antimicrob Agents Chemother 2004; 48: 3185-7.
-
(2004)
Antimicrob Agents Chemother
, vol.48
, pp. 3185-3187
-
-
Ito, M1
Yasuda, M2
Yokoi, S3
-
2
-
-
84933049453
-
The second nationwide surveillance of the antimicrobial susceptibility of Neisseria gonorrhoeae from male urethritis in Japan, 2012-2013
-
Hamasuna R, Yasuda M, Ishikawa K et al. The second nationwide surveillance of the antimicrobial susceptibility of Neisseria gonorrhoeae from male urethritis in Japan, 2012-2013. J Infect Chemother 2015; 21: 340-5.
-
(2015)
J Infect Chemother
, vol.21
, pp. 340-345
-
-
Hamasuna, R1
Yasuda, M2
Ishikawa, K3
-
3
-
-
84870998337
-
Guidelines for the diagnosis and treatment of sexually transmitted diseases 2011
-
Japanese Society for Sexually Transmitted Diseases. Suppl
-
Japanese Society for Sexually Transmitted Diseases. Guidelines for the diagnosis and treatment of sexually transmitted diseases 2011. Jpn J Sex Transm Dis 2011; 22 Suppl: 52-9.
-
(2011)
Jpn J Sex Transm Dis
, vol.22
, pp. 52-59
-
-
-
4
-
-
51349130594
-
Single dose 1 g ceftriaxone for urogenital and pharyngeal infection caused by Neisseria gonorrhoeae
-
Muratani T, Inatomi H, Ando Y et al. Single dose 1 g ceftriaxone for urogenital and pharyngeal infection caused by Neisseria gonorrhoeae. Int J Urol 2008; 15: 837-42.
-
(2008)
Int J Urol
, vol.15
, pp. 837-842
-
-
Muratani, T1
Inatomi, H2
Ando, Y3
-
5
-
-
84930940449
-
Sexually transmitted diseases treatment guidelines, 2015
-
CDC. RR-03
-
Workowski KA, Bolan GA; CDC. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep 2015; 64 RR-03: 1-137.
-
(2015)
MMWR Recomm Rep
, vol.64
, pp. 1-137
-
-
Workowski, KA1
Bolan, GA2
-
6
-
-
84879495636
-
2012 European guideline on the diagnosis and treatment of gonorrhoea in adults
-
European STI Guidelines Editorial Board
-
Bignell C, Unemo M; European STI Guidelines Editorial Board. 2012 European guideline on the diagnosis and treatment of gonorrhoea in adults. Int J STD AIDS 2013; 24: 85-92.
-
(2013)
Int J STD AIDS
, vol.24
, pp. 85-92
-
-
Bignell, C1
Unemo, M2
-
8
-
-
79959189164
-
Is Neisseria gonorrhoeae initiating a future era of untreatable gonorrhea?: detailed characterization of the first strain with high-level resistance to ceftriaxone
-
Ohnishi M, Golparian D, Shimuta K et al. Is Neisseria gonorrhoeae initiating a future era of untreatable gonorrhea?: detailed characterization of the first strain with high-level resistance to ceftriaxone. Antimicrob Agents Chemother 2011; 55: 3538-45.
-
(2011)
Antimicrob Agents Chemother
, vol.55
, pp. 3538-3545
-
-
Ohnishi, M1
Golparian, D2
Shimuta, K3
-
9
-
-
84939529739
-
Current and future antimicrobial treatment of gonorrhoea-the rapidly evolving Neisseria gonorrhoeae continues to challenge
-
Unemo M. Current and future antimicrobial treatment of gonorrhoea-the rapidly evolving Neisseria gonorrhoeae continues to challenge. BMC Infect Dis 2015; 15: 364.
-
(2015)
BMC Infect Dis
, vol.15
, pp. 364
-
-
Unemo, M.1
-
10
-
-
84950273190
-
New clinical strain of Neisseria gonorrhoeae with decreased susceptibility to ceftriaxone, Japan
-
Deguchi T, Yasuda M, Hatazaki K et al. New clinical strain of Neisseria gonorrhoeae with decreased susceptibility to ceftriaxone, Japan. Emerg Infect Dis 2016; 22: 142-4.
-
(2016)
Emerg Infect Dis
, vol.22
, pp. 142-144
-
-
Deguchi, T1
Yasuda, M2
Hatazaki, K3
-
11
-
-
85013271556
-
Novel penA mutations identified in Neisseria gonorrhoeae with decreased susceptibility to ceftriaxone isolated between 2000 and 2014 in Japan
-
Seike K, Yasuda M, Hatazaki K et al. Novel penA mutations identified in Neisseria gonorrhoeae with decreased susceptibility to ceftriaxone isolated between 2000 and 2014 in Japan. J Antimicrob Chemother 2016; 71: 2466-70.
-
(2016)
J Antimicrob Chemother
, vol.71
, pp. 2466-2470
-
-
Seike, K1
Yasuda, M2
Hatazaki, K3
-
12
-
-
80052845543
-
Japanese guideline for clinical research of antimicrobial agents on urogenital infections: the first edition
-
Yasuda M, Takahashi S, Kiyota H et al. Japanese guideline for clinical research of antimicrobial agents on urogenital infections: the first edition. J Infect Chemother 2011; 17: 579-94.
-
(2011)
J Infect Chemother
, vol.17
, pp. 579-594
-
-
Yasuda, M1
Takahashi, S2
Kiyota, H3
-
15
-
-
0028940924
-
Drugs of choice for the treatment of uncomplicated gonococcal infections
-
Suppl 1
-
Moran JS, Levine WC. Drugs of choice for the treatment of uncomplicated gonococcal infections. Clin Infect Dis 1995; 20 Suppl 1: S47-65.
-
(1995)
Clin Infect Dis
, vol.20
, pp. S47-S65
-
-
Moran, JS1
Levine, WC.2
-
17
-
-
77957231790
-
Cephalosporin MIC creep among gonococci: time for a pharmacodynamic rethink?
-
Chisholm SA, Mouton JW, Lewis DA et al. Cephalosporin MIC creep among gonococci: time for a pharmacodynamic rethink? J Antimicrob Chemother 2010; 65: 2141-8.
-
(2010)
J Antimicrob Chemother
, vol.65
, pp. 2141-2148
-
-
Chisholm, SA1
Mouton, JW2
Lewis, DA3
-
18
-
-
84900500899
-
In vitro synergy testing of novel antimicrobial combination therapies against Neisseria gonorrhoeae
-
Barbee LA, Soge OO, Holmes KK et al. In vitro synergy testing of novel antimicrobial combination therapies against Neisseria gonorrhoeae. J Antimicrob Chemother 2014; 69: 1572-8.
-
(2014)
J Antimicrob Chemother
, vol.69
, pp. 1572-1578
-
-
Barbee, LA1
Soge, OO2
Holmes, KK3
|